Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Kariminejad - Najmabadi Pathology & Genetics Center, Tehran, Iran.
Arch Iran Med. 2023 May 1;26(5):279-284. doi: 10.34172/aim.2023.43.
Charcot-Marie-Tooth disease type 4G (CMT4G) was first reported in Balkan Gypsies as a myelinopathy starting with progressive distal lower limb weakness, followed by upper limb involvement and prominent distal sensory impairment later in the patient's life. So far, CMT4G has been only reported in European Roma communities with two founder homozygous variants; g.9712G>C and g.11027G>A, located in the 5'-UTR of the gene. Here, we present the first Iranian CMT4G patient manifesting progressive distal lower limb weakness from 11 years of age and diagnosed with chronic demyelinating sensorimotor polyneuropathy. Whole-exome sequencing for this patient revealed a homozygous c.19C>T (p. Arg7*) variant in the gene. This report expands the mutational spectrum of the -related CMT disorder and provides supporting evidence for the observation of CMT4G outside the Roma population. Interestingly, the same Arg7* variant is recently observed in another unrelated Pakistani CMT patient, proposing a possible prevalence of this variant in the Middle Eastern populations.
Charcot-Marie-Tooth 病型 4G(CMT4G)最初在巴尔干吉普赛人中被报道为一种脱髓鞘疾病,其起始表现为进行性远端下肢无力,随后在患者的后期生活中出现上肢受累和明显的远端感觉障碍。到目前为止,CMT4G 仅在欧洲罗姆人社区中被报道,有两个创始性纯合变体:g.9712G>C 和 g.11027G>A,位于 基因的 5'-UTR 中。在这里,我们报告了首例伊朗 CMT4G 患者,其表现为 11 岁时进行性远端下肢无力,并被诊断为慢性脱髓鞘感觉运动性多发性神经病。对该患者进行全外显子组测序显示, 基因中存在 c.19C>T(p.Arg7*)纯合变体。本报告扩展了 - 相关 CMT 疾病的突变谱,并为在罗姆人以外的人群中观察到 CMT4G 提供了支持证据。有趣的是,最近在另一位无关联的巴基斯坦 CMT 患者中也观察到了相同的 Arg7*变体,提示该变体可能在中东人群中普遍存在。